Decoded: Understanding the debate over coronavirus booster shots

US Centers for Disease Control and Prevention recommends that ad­ults receive boosters of the tetanus vaccine every dec­a­de

vaccine
Photo: Shutterstock
Robert Langreth | Bloomberg
3 min read Last Updated : Aug 12 2021 | 9:46 PM IST
With the especially contagious delta variant threatening efforts to end the pandemic, a growing number of wealthy countries are planning or considering administering booster shots of Covid-19 vaccines, at least to particularly vulnerable groups. Officials at the World Health Organization have characterised this course of action as unethical as long as poorer countries still lack supplies to cover significant portions of their populations with initial doses. They argue that the strategy could wind up prolonging the pandemic, as well.

What’s a booster shot?

The term traditionally has re­f­er­red to an additional dose of a vaccine given some time after the initial course of inoculation to bolster protection that may have started to wane. While many vaccines produce long-lasting immunity, the US Centers for Disease Control and Prevention recommends that ad­ults receive boosters of the tetanus vaccine every dec­a­de, for example. For Covid-19, a new disease, rese­archers are working out the optimal schedule and dos­a­ge for a variety of vaccines on the fly in the midst of a pandemic. The term booster is being used loosely to refer to additional shots given for a variety of reasons to people who have already received the prescribed course of a Covid vaccine.

What are the reasons?

There’s a small group of people with weakened immune systems, such as transplant recipients, who are likely to need an additional shot sooner rather than later. The extra shot isn’t a traditional booster, as these people likely never get an adequate response to an initial course of Covid vaccine. For the rest of the population, an additional shot (or shots) may prove to be helpful if immunity wanes over time, or alternatively, if new coronavirus variants emerge that evade vaccine protection. In the first scenario, giving another dose of the original vaccine may be sufficient. That’s mostly what is being considered for the immediate future. In the second scenario, shots customised against new variants may be needed.

Which countries have signed on to extra Covid shots?

Countries that have started or decided to offer them to especially vulnerable groups inc­l­ude Israel, Germany and Fra­n­ce. Offering them more broad­ly to people months after their last dose are Russia, Hungary and the United Arab Emirates. Some nations plan to give extra shots using a vaccine type that’s different from the one people got initially. This mix-and-match strategy is called a heterologous boost, and there’s some evidence it can provide an advantage over an additional dose of the same formulation.

How are decisions about boosters made?

Since there is no scientific consensus for when booster shots become necessary, deciding when to employ another dose is a judgement call by public health officials. Accordingly, countries may make different decisions. In the US, the Food and Drug Administration official in charge of vaccine regulation, Peter Marks, has said that the US doesn’t have a “predetermined minimum” for how much efficacy must fade before it authorises booster shots, and will look at the totality of the evidence before making decisions. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusDelta variant of coronavirusCoronavirus TestsCoronavirus VaccineVaccineVaccinationWorld Health Organization

Next Story